Expression of CD154 (CD40L) on stimulated T lymphocytes in patients with idopathic thrombocytopenic purpura

References

• Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest. 1998;102(7):1393–402. doi: 10.1172/JCI4238
   PubMed Web of Science ®Google Scholar
• Jiang H, Chess L. An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest. 2004;114(9):1198–208. doi: 10.1172/JCI23411
   PubMed Web of Science ®Google Scholar
• Koshy M, Berger D, Crow MK. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest. 1996;98(3):826–37. doi: 10.1172/JCI118855
   PubMed Web of Science ®Google Scholar
• Berner B, Wolf G, Hummel KM, Muller GA, Reuss-Borst MA. Increased expression of CD40 ligand (CD154) on CD4+T cells as a marker of disease activity in rheumatoid arthritis. Ann Rheum Dis. 2000;59(3):190–5. doi: 10.1136/ard.59.3.190
   PubMed Web of Science ®Google Scholar
• Daoussis D, Antonopoulos I, Andonopoulos AP, Liossis SN. Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis. Rheumatology 2007;46(2):227–31. doi: 10.1093/rheumatology/kel229
   PubMed Web of Science ®Google Scholar
• Solanilla A, Pasquet JM, Viallard JF, Contin C, Grosset C, Dechanet-Merville J, et al. Platelet-associated CD154 in immune thrombocytopenic purpura. Blood 2005;105(1):215–8. doi: 10.1182/blood-2003-07-2367
   PubMed Web of Science ®Google Scholar
• Patel VL, Schwartz J, Bussel JB. The effect of anti-CD40 ligand in immune thrombocytopenic purpura. Br J Haematol. 2008;141(4):545–8. doi: 10.1111/j.1365-2141.2008.07039.x
   PubMed Web of Science ®Google Scholar
• Kuwana M, Nomura S, Fujimura K, Nagasawa T, Muto Y, Kurata Y, et al. Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura. Blood 2004;103(4):1229–36. doi: 10.1182/blood-2003-06-2167
   PubMed Web of Science ®Google Scholar
• Webber NP, Mascarenhas JO, Crow MK, Bussel J, Schattner EJ. Functional properties of lymphocytes in idiopathic thrombocytopenic purpura. Hum Immunol. 2001;62(12):1346–55. doi: 10.1016/S0198-8859(01)00348-2
   PubMed Web of Science ®Google Scholar
• Meabed MH, Taha GM, Mohamed SO, El-Hadidy KS. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes. Hematology 2007;12(4):301–7. doi: 10.1080/10245330701383957
   PubMed Web of Science ®Google Scholar
• Vakkalanka RK, Woo C, Kirou KA, Koshy M, Berger D, Crow MK. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. Arthritis Rheum. 1999;42(5):871–81. doi: 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J
   PubMed Web of Science ®Google Scholar
• Tamura N, Kobayashi S, Kato K, Bando H, Haruta K, Oyanagi M, et al. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis. J Rheumatol. 2001;28(12):2583–90.
   PubMed Web of Science ®Google Scholar
• Nagahama M, Nomura S, Kanazawa S, Ozaki Y, Kagawa H, Fukuhara S. Significance of chemokines and soluble CD40 ligand in patients with autoimmune thrombocytopenic purpura. Eur J Haematol. 2002;69(5–6):303–8. doi: 10.1034/j.1600-0609.2002.02774.x
   PubMed Web of Science ®Google Scholar
• Feng X, Scheinberg P, Samsel L, Rios O, Chen J, McCoy Jr. JP, et al. Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura. J Thromb Haemost. 2012;10(8):1616–23. doi: 10.1111/j.1538-7836.2012.04757.x
   PubMed Web of Science ®Google Scholar
• Neunert C, Lim W, Crowther M, Cohen A, Solberg Jr. L, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117(16):4190–207. doi: 10.1182/blood-2010-08-302984
   PubMed Web of Science ®Google Scholar
• Notarangelo LD, Peitsch MC, Abrahamsen TG, Bachelot C, Bordigoni P, Cant AJ, et al. CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 1996;17(11):511–6. doi: 10.1016/S0167-5699(96)80904-2
   PubMedGoogle Scholar
• Sousa AE, Chaves AF, Doroana M, Antunes F, Victorino RM. Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery. Clin Exp Immunol. 1999;116(2):307–15. doi: 10.1046/j.1365-2249.1999.00872.x
   PubMed Web of Science ®Google Scholar
• Younes A, Snell V, Consoli U, Clodi K, Zhao S, Palmer JL, et al. Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukaemia. Br J Haematol. 1998;100(1):135–41. doi: 10.1046/j.1365-2141.1998.00522.x
   PubMed Web of Science ®Google Scholar
• Goules A, Tzioufas AG, Manousakis MN, Kirou KA, Crow MK, Routsias JG. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J Autoimmun. 2006;26(3):165–71. doi: 10.1016/j.jaut.2006.02.002
   PubMed Web of Science ®Google Scholar
• Fan Y, Ge Y, Zhu H, Wang Y, Yang B, Zhuang Y, et al. Characterization and application of two novel monoclonal antibodies against CD40L: epitope and functional studies on cell membrane CD40L and studies on the origin of soluble serum CD40L. Tissue Antigens 2004;64(3):257–63. doi: 10.1111/j.1399-0039.2004.00257.x
   PubMed Web of Science ®Google Scholar
• Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002;106(8):896–9. doi: 10.1161/01.CIR.0000028962.04520.01
   PubMed Web of Science ®Google Scholar
• Viallard JF, Solanilla A, Gauthier B, Contin C, Dechanet J, Grosset C, et al. Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood 2002;99(7):2612–4. doi: 10.1182/blood.V99.7.2612
   PubMed Web of Science ®Google Scholar
• Sipsas NV, Sfikakis PP, Kontos A, Kordossis T. Levels of soluble CD40 ligand (CD154) in serum are increased in human immunodeficiency virus type 1-infected patients and correlate with CD4(+) T-cell counts. Clin Diagn Lab Immunol. 2002;9(3):558–61.
   PubMedGoogle Scholar